BioFactura, Inc. to Present at the Biotech Showcase™ Annual Conference on January 10th, 2018

Frederick, Maryland


Jeffrey N. Hausfeld MD, MBA, Chairman and Chief Medical Officer, today announced that BioFactura will present at Biotech Showcase™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.

Date: Wednesday, January 10, 2018

Time: 3:15 PM (PST)

Room: Yosemite -B (Ballroom Level)

Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)

BioFactura Inc.  develops and commercializes high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast ™ Biomanufacturing Platform, the optimal system for bringing these drugs to market with faster, lower cost, superior-quality manufacture.

BioFactura is focusing on NS0 and SP2/0 mouse cell based biologics production technologies as compared to the more broadly used hamster cell based CHO platforms.  While CHO platforms are ubiquitous, BioFactura’s NS0-based StableFast ™ platform presents a unique, proprietary gateway to the high-barrier mouse cell line-based biosimilars.

BioFactura has developed a fully integrated drug development and clinical manufacturing facility allowing us to support our biosimilars product development programs as well as provide contract services in cell line development, process development, and Phase I/II GMP manufacturing for industrial, academic, and government institutions.

Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.

Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that [Company Name] will be [presenting] at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”

Contact Information:

Jeffrey N. Hausfeld MD, MBA

jhausfeld@biofactura.com

www.biofactura.com

Follow Biotech Showcase on Twitter: @EBDGroup and @Demy_Colton  – #BiotechShowcase

 

January 2, 2018 Press Releases
About BioFactura

BioFactura (Frederick MD) develops and commercializes high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast Biomanufacturing Platform, the optimal system for bringing these drugs to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.